Skip to content

Clinical trials

Recruiting Primary Immunodeficiency Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Immunodeficiency Diseases Status: Recruiting Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20111
20141
20151
20161
20171
20183
20191
20207
20212
20222
20233
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)10
New York Medical College4
Paul Szabolcs2
Assistance Publique - Hôpitaux de Paris1
Biopharma Plasma LLC1
Children's National Research Institute1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Gazi University1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Icahn School of Medicine at Mount Sinai1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Immunodeficiency Diseases34
Immune System Diseases4
Immunologic Deficiency Syndromes4
Autoimmune Diseases3
Congenital Bone Marrow Failure Syndromes3
Granulomatous Disease, Chronic3
Inflammatory Bowel Diseases3
Adrenoleukodystrophy2
Anemia, Diamond-Blackfan2
Anemia, Sickle Cell2

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.